The Anne T. Bass Endowed Lectureship in Hematology, Oncology and Stem Cell Transplantation

The Lifetime Impact of Childhood Cancer and Cancer Therapy
 

PRESENTED BY
Gregory Armstrong, MD, MSCE
Member, St. Jude Faculty
Co-Leader, Cancer Control & Survivorship Program
St. Jude Children's Research Hospital
 

SESSION DESCRIPTION
Childhood cancer survival rates have significantly improved over the past 50 years with over 85% of all children diagnosed with cancer now expected to survive at least five years. However, survival comes at a cost, including increased risk for chronic health conditions, with over 80% of childhood cancer survivors experiencing a severe, life-threatening or fatal (CTCAE grade 3-5) chronic health condition by age 45 years. The lecture will highlight risk and risk factors for these late effects as well as interventions designed to change the trajectory of these late effects.

EDUCATION GOALS

• Rethinking success in pediatric oncology: Beyond 5-year survival
• Rationale for a survivor cohort, CCSS methodology
• Model for late effects research. Latest results from CCSS with the overarching goal of translating findings into effective strategies that reduce risk for treatment- related complications and improve the quality of life survivors.
   

LOCATION (in-person)
LPCH Auditorium - West Building
725 Welch Road
Palo Alto, CA 94304

ZOOM INFORMATION
Subscribe to receive weekly email announcements and Zoom webinar information for each session.
Subscribe to mailing list